Navigation Links
St. Jude Study Finds Treatment With New Drug Might Make Tumor Cells More Sensitive to Therapy
Date:9/16/2008

Study shows treatment with a newly discovered drug could be useful in sensitizing tumor cells to therapeutic irradiation and potentially some chemotherapies

MEMPHIS, Tenn., Sept. 16 /PRNewswire-USNewswire/ -- Scientists at St. Jude Children's Research Hospital have shown that it might be possible to make tumor cells more sensitive to irradiation and some types of chemotherapy by treating them with a drug that cripples their ability to repair DNA damage caused by these therapies.

The St. Jude researchers demonstrated in the laboratory that a molecule called CP466722 rapidly blocks the ATM protein's ability to orchestrate a series of biochemical events that culminate in the repair of DNA damaged by irradiation. The molecule exerted its effect in small quantities, and its effects rapidly ended after it was removed from cells, suggesting that such a treatment in humans would not have significant or long-term side effects, the researchers said.

Results of the study were published in the Sept. 15 issue of the journal Cancer Research.

ATM plays a critical role in repairing a type of DNA damage called double-strand breaks, in which each of the two strands making up this molecule are cut, according to Michael Kastan, M.D., Ph.D., director of the St. Jude Comprehensive Cancer Center. This process protects cells from the potentially lethal or mutation-causing effects of free oxygen radicals and irradiation--both of which routinely threaten them, he added. Kastan is senior author of the report on these findings.

Children lacking the gene for ATM develop ataxia-teleangiectasia, a disease that causes several debilitating problems, such as neurodegeneration, cancer and sensitivity to irradiation that leads to irreparable, double-stranded DNA breaks.

"We found that inhibition of ATM activity with CP466722 produces cellular effects that are identical to those seen in cells that lack ATM," Kastan said. "It's as if we temporarily turn
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
2. New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
3. Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative
4. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
5. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
6. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimers Disease
7. Most Cancer Treatment Studies Arent Published, Study Finds
8. Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA
9. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
10. Screening for Ischemia in Asymptomatic Patients With Type 2 Diabetes: Five- Year Outcomes in the DIAD Study
11. What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... NEW YORK , June 17, 2013  A little ... has come under scrutiny by the U.S. Supreme Court – ... on the issue could not have come at a better ... issues that result from the Rx industry tactic are all ... AARP survey of 50+ New Yorkers, state residents are in ...
(Date:6/17/2013)... 2013 Franciscan St. Francis Health Cancer Center ... Indiana to use a new drug ... It,s called Xofigo ®, a radiopharmaceutical used in patients ... It recently was approved for use by the U.S. Food ... advanced stages it may become castration-resistant, which has become resistant ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013  The ... the most comprehensive report on the effectiveness of ... restrictions on these FDA-approved drugs by many state ... more Americans than drunk driving car crashes, an ... and use of heroin. Yet, safe and effective ...
Breaking Medicine Technology:Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 3New drug proving effective in attacking advanced prostate cancer 2Effective Rx thwarted for deadly opiate epidemic 2
... Into a Collaborative Research Agreement With The University of Texas M. ... Breast ... Cancer, VEDBAEK, ... analysis products, today,announces that it has signed a collaborative research agreement with ...
... Approved in 40 Countries ... ... Massachusetts, May 27, Shire Limited (LSE: SHP, NASDAQ: SHPGY), the,global ... therapy for the treatment of,Hunter syndrome, has been approved by ...
Cached Medicine Technology:Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 2Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:6/17/2013)... June 17, 2013 "Do you think you ... texting, emailing or using your phone even with a hands ... it is just as dangerous as not using a hands ... of you using Facebook, texting, emailing etc." , ... alters their reflexes that distract the brain, according to a ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Bust’DD (pronounced ‘busted’), ... stylish and well-fitting to women with large busts, will soon ... by two women who understand the problem of ill-fitting bras ... busty women. Their goal is to raise at least $25,000 ... of offering their bras on a wide scale. , In ...
(Date:6/17/2013)... June 17, 2013 The personal ... LLP are pleased to announce that firm Partners ... L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will be appearing ... FM) this Sunday, June 23, 2013 at 7a.m. ... guests on Kevin Burke's "Get Active" show, which ...
(Date:6/17/2013)... Park City, Utah (PRWEB) June 17, 2013 ... information on stand-alone HRAs for small businesses ... alternatives to traditional employer sponsored health benefits, is ... health reimbursement arrangements . , According to ... called Health Reimbursement Accounts or HRAs, offer small ...
(Date:6/17/2013)... According to a June 11, 2013 ABC ... and more information surfaces about the negative effects of ... part of one’s skin care routine, as the ... goo.gl/qTKZQ). , “I agree with the article's suggestions for ... Medical Director of Epione Beverly Hills. “Apply a minimum of ...
Breaking Medicine News(10 mins):Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Zane Benefits Publishes New Information on Stand-Alone HRAs for Small Businesses 2Health News:Skin Care – Answers to Your Sunscreen Questions 2
... connectivity for ... Cardiac Rehabilitation, BOTHELL, ... a global leader in advanced cardiac monitoring,and defibrillation products, announced ... now has seamless connectivity with LUMEDX,CardioWellness(TM) data management software. ...
... as Evelyn Bickley wins CBay,s ,Keys to Medical ... Records ... leading provider,of transcription and healthcare BPO services, today announced the ... year,s AHIMA,Convention and Exhibit in Philadelphia. (Photo: http://www.newscom.com/cgi-bin/prnh/20071017/NEW009 ...
... Inc.,(Nasdaq: ATRC ), a medical device company ... that results reporting on the Company,s,proprietary minimally invasive ... (AF), were published in the Journal of,Cardiovascular Electrophysiology ... from the Oregon Heart and Vascular,Institute. The ...
... WASHINGTON, Oct. 16 Speaker Nancy Pelosi,Senate Majority Leader ... Paul Simon, Families USA, Easter Seals, and other advocates ... Congress to override the,President,s veto of the Children,s Health ... Ron Pollack, to Families USA, to Easter Seals, and ...
... Stock Exchange Symbol: CYT, MONTREAL, Oct. ... leader in cardiac arrhythmia products to treat ... Inc. a patent,infringement lawsuit in the United ... CryoCor makes and sells cryosurgical consoles, ...
... 1st issue of G&D, Dr. Michael Cleary (Stanford University ... as a critical player in the establishment of leukemia ... Mixed lineage leukemia (MLL) is a distinctive type of ... leukemia (ALL) by the presence of a break and ...
Cached Medicine News:Health News:Cardiac Science Announces Data Connectivity with LUMEDX 2Health News:Cardiac Science Announces Data Connectivity with LUMEDX 3Health News:Cardiac Science Announces Data Connectivity with LUMEDX 4Health News:CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3Health News:Pelosi: In 48 Hours, Congress Must Choose Between Meeting the Needs of America's Children or Not 2
... Engine is a core software ... System, which enables location-based applications ... Core capabilities of the AeroScout ... positioning, management of AeroScout hardware ...
... Bracelet-ID™ provides a solution for instantaneously ... elopement or unauthorized movement of patients ... a key concern. Certain patients, such ... victims, patients with highly communicable diseases, ...
... Kisses tag is part of the ... Hugs system. The Kisses tag is ... it has been bonded with the ... he two tags remain electronically bonded ...
... small radio transmitter combines state-of-the-art microprocessor ... The tag incorporates a tamper mechanism ... the tag is attached to the ... Heartbeat® signal every 10 seconds to ...
Medicine Products: